Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (13,446,538)	$ (8,424,440)	$ (8,563,455)
Adjustments to reconcile net loss to net cash used in operating activities
Preferred shares issued as compensation	230,897	237,868	524,258
Loss on issuance of preferred shares for accounts payable- related party	142,669	0	0
Common shares issued as compensation and for services	328,501	282,532	266,906
Common shares issued for debenture interest		0	60,274
Options granted as compensation		11,920	0
Warrants granted to Scientific Advisory Board	7,373	5,475	16,770
Warrants granted for severance agreement		0	53,500
Depreciation	691,454	687,640	671,789
Amortization	8,270	8,271	8,269
Amortization of loan origination fees	21,288	0	0
Change in fair value of derivative liabilities	5,845,313	(179,745)	(2,554,020)
Gain on warrant settlement	(614,494)	0	0
Amortization of debt discount convertible debentures		0	359,214
Loss on extinguishment of debt		0	1,348,247
Changes in operating assets and liabilities:
Prepaid expenses	(6,849)	(29,957)	(50,091)
Other long term assets	15,513	(21,025)	50,767
Accounts payable	122,834	86,554	87,553
Accounts payable - related parties	(12,203)	716,315	(233,227)
Accrued expenses	369	(184,178)	219,045
Deferred interest payable		0	(41,667)
NET CASH USED IN OPERATING ACTIVITIES	(6,665,603)	(6,802,770)	(7,775,868)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(8,638)	(73,794)	(241,822)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from note payable -related party	1,100,000	0	0
Net proceeds from issuance of common stock and warrants	16,676,975	2,350,000	0
Deferred financing costs	(12,190)	0	0
Proceeds from loan payable	155,173	0	0
Payment of loan payable	(92,330)	0	0
NET CASH PROVIDED BY FINANCING ACTIVITIES	17,827,628	2,350,000	0
NET CHANGE IN CASH AND CASH EQUIVALENTS	11,153,387	(4,526,564)	(8,017,690)
Cash and cash equivalents at beginning of period	2,555,207	7,081,771	15,099,461
Cash and cash equivalents at end of period	13,708,594	2,555,207	7,081,771
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid		0	166,667
Income tax paid		0	0
NON CASH FINANCING AND INVESTING ACTIVITIES:
Cashless exercise of warrants reclassed from warrant liability to common stock	1,153,881	0	0
Series A preferred stock issued for accounts payable-related party	250,000	0	0
Series A preferred stock issued for loan origination fee	39,301	0	0
Common stock issued to settle accounts payable	$ 52,000	0	0
Common stock issued for debenture payment		0	230,250
Common stock issued for deferred interest		0	6,250
Series A Preferred stock issued for Series C debenture		0	15,718
Stock warrants classified as a liability issued in connection with registered direct offering		$ 76,363	$ 0